TrialPloS one2012

A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults.

Michael C Keefer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.